Market Research
U.S. Legal Cannabis Sales Hit $2.3B in December, Lifting 2025 Total to $27B
LOS ANGELES – Legal Cannabis sales across the United States ...
iAnthus Reports Q1 2026 Financial Results
NEW YORK-TORONTO – iAnthus Capital Holdings posted its fiscal first-quarter ...
Organigram Reports Q2 Fiscal 2026 Results
TORONTO – Organigram Global Inc. released its financial results, marking ...
Hemp-Derived THC Beverages Gain Traction as U.S. Alcohol Consumption Declines
LOS ANGELES – Hemp-derived THC beverages generated $382 million in sales in 2024, a marked increase from previous years, yet 2025 projections indicate tempered growth at $571 million, climbing to $756 million by 2029 with ...
Cannabis MSOs Face High-Stakes Tax Dilemma as Rescheduling Decision Looms Under Trump
As Trump's administration weighs reclassifying Cannabis to Schedule III, Cannabis giants continue to contend with hefty uncertain tax liabilities under IRS Section 280E, a rule that has long hampered their financial flexibility. A recent report ...
Cresco Labs Reports Q1 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...
Cronos Group Reports Q1 2026 Financial Results
TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...
